AbbVie Stock: Fourth Quarter Comes In Mixed, But Earnings Guidance Beats

AbbVie stock ticked down early Wednesday after the pharmaceutical company reported adjusted earnings of $3.31 per share on $14.89 billion in fourth-quarter sales.

X

On average, analysts polled by FactSet expected AbbVie (ABBV) to report earnings of $3.28 a share and $14.95 billion in sales.

In the year-earlier period, AbbVie earned $2.92 per share and reported $13.86 billion in sales.

For the year ending in December 2022, AbbVie guided to adjusted earnings of $14-$14.20 per share. AbbVie stock analysts forecasted adjusted profit of $13.99 a share and $59.85 billion in sales.

In premarket trading on today’s stock market, AbbVie stock dipped a fraction near 136.40.

More to follow.

Follow Allison Gatlin on Twitter at @IBD_AGatlin.

YOU MAY ALSO LIKE:

Pfizer Backs Out Of Deal, But Former Partner Ionis Pares Its Losses

Will Moderna Sidestep The Looming Sales Cliff After FDA Approves Covid Shot?

Want To Get Quick Profits And Avoid Big Losses? Try SwingTrader

Find Today’s Best Growth Stocks To Watch With IBD 50

Best Growth Stocks To Buy And Watch: See Updates To IBD Stock Lists